SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-21-000165
Filing Date
2021-06-21
Accepted
2021-06-21 10:23:19
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-K rgbp093019form10k.htm 10-K 2139498
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9499
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9478
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4225
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4096
  Complete submission text file 0001607062-21-000165.txt   6009793

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20190930.xml EX-101.INS 921718
7 XBRL SCHEMA FILE rgbp-20190930.xsd EX-101.SCH 67116
8 XBRL CALCULATION FILE rgbp-20190930_cal.xml EX-101.CAL 55495
9 XBRL DEFINITION FILE rgbp-20190930_def.xml EX-101.DEF 196358
10 XBRL LABEL FILE rgbp-20190930_lab.xml EX-101.LAB 325589
11 XBRL PRESENTATION FILE rgbp-20190930_pre.xml EX-101.PRE 260269
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 211028241
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences